Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase
- 21 June 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 294 (4) , 813-817
- https://doi.org/10.1016/s0006-291x(02)00560-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- New cytotoxic agents and schedules for advanced breast cancerSeminars in Oncology, 2001
- Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell LeukemiaNew England Journal of Medicine, 2001
- Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomasOncogene, 2001
- The RET proto-oncogene in human cancersOncogene, 2000
- Demystified ...: Monoclonal antibodiesMolecular Pathology, 2000
- Improved Gene Transfer to Neuroblastoma Cells by a Monoclonal Antibody Targeting RET, a Receptor Tyrosine KinaseHuman Gene Therapy, 2000
- The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up‐regulated upon differentiationBritish Journal of Haematology, 1999
- Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cellsBritish Journal of Haematology, 1999
- Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2BScience, 1995
- trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stagesInternational Journal of Cancer, 1993